Developing the Next Generation of Gene Editing Tools

Explore Your Topic

Curevac and Bayer Join Forces on COVID-19 Vaccine Candidate

Werner Baumann on Scientific Innovation

The Yin and Yang of Progress

Key Defenses in the Pandemic

How to Strengthen Your Immune System and Protect Others

Our Products

Can We Live Better?

Can 10 billion of us live better?

Working Together for Health for All, Hunger for None

Science at Home

What’s Up with Global Warming?

Uses and Safety Record

Let’s Talk About Glyphosate

Links

Information for Patients

Modern Slavery Act Statement.pdf (PDF 2.05 MB)

Latest News

Share Price / Index

January 20, 2021 17:41 CEST

January 20, 2021 17:55 CEST

January 20, 2021

Not intended for U.S. and UK Media

U.S. FDA approves vericiguat for patients with symptomatic chronic heart failure

January 13, 2021

Not intended for U.S. and UK Media - Virtual Bayer Pharma Media Day:

Bayer transforms pharma business through breakthrough innovation in healthcare

January 12, 2021

Not intended for U.S. and UK Media

U.S. FDA grants Priority Review to New Drug Application for finerenone to treat patients with chronic kidney disease and type 2 diabetes

Advance Your Career

Why Bayer

Working at Bayer

Meet Our Employees

Open Jobs

Operational Excellence Experte (m/w/d)

Germany Bitterfeld-Wolfen

Chemikant im Entwicklungstechnikum (m/w/d)

Germany Bergkamen

Process Control Eng. Multi Purpose Plant (m/f/d)

Germany Dormagen

Explore Our Businesses

We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here.

Pharmaceuticals

Consumer Health